drugset / Trial / NCT03885882

A Pharmacokinetic (PK) Study of Three Types of E0302 Sustained Release (SR) Tablets Compared With E0302 Immediate Release (IR) Tablet Under Fed Conditions in Healthy Participants

NCT03885882 ↗

Phase 1 Completed 24 enrolled Eisai Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

To assess the PK and safety after administration of three types of E0302 SR tablets (SR1, SR2, SR3) and E0302 IR tablet.

Timeline

Start
2019-04-13
Primary completion
2019-06-26
Completion
2019-06-26

Drugs

EvaluationDrugModalityDoseRoute
Subject E0302 Unknown 500 ug Oral
Subject E0302 Unknown 1500 ug Oral

Indications

No indication recorded.